slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 29,581-29,610
Pages 1,935
Rows per page 30
Slide function
29,581-29,610 of 58,039
42
R&R stands for Repair and Remodel. The slide uses donut charts to visualize market exposure percentages.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Action1 hit
56
The slide highlights an acceleration in growth for the company's largest dealer cohorts.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Action1 hit
112
Includes a custom 'SEED' acronym graphic for safety culture.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Action1 hit
07
The slide uses a central donut chart for total monthly plays and gender split, flanked by two bar charts for age and geography.Azerion | Investor Presentation Deck | 25 slides · Azerion
Pitch deck Investor relations Beat · Business ModelLoop · Golden Circle1 hit
18
Includes adjustments for exchange rates, divestitures, and discontinuations.Bausch Health Companies | Shareholder Engagement Presentation Deck | 19 slides · Bausch Health
Shareholder letter Investor relations 1 hit
19
Includes non-GAAP reconciliation disclosure.Bausch Health Companies | Shareholder Engagement Presentation Deck | 19 slides · Bausch Health
Shareholder letter Investor relations 1 hit
16
Bigbear AI | Investor Conference Presentation Deck | 21 slidesBigbear AI | Investor Conference Presentation Deck | 21 slides · BigBear.ai
Conference presentation Investor relations Beat · Financials1 hit
25
Source: Lang F, et al. Nature Rev Drug Discov 2022; 21:261-282.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
26
The chart uses a broken y-axis to show high-frequency outliers alongside the long tail of low-frequency targets.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
31
The slide uses a combination of microscopy images and a line chart to demonstrate efficacy.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
41
The slide illustrates the methodology for ranking neoantigens, likely for personalized cancer vaccine development.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
44
The slide shows structural models of spike proteins (Wuhan, Beta, Omicron) alongside scatter plots correlating epitope alteration/semantic change/immune escape scores with pVNT50 reduction and ACE2 binding affinity.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
45
The chart displays genetic mutations (columns) against specific viral lineages (rows). Colors indicate mutation status (common vs. not common) and potentially other metrics.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
67
The table highlights that all tested Omicron-modified vaccines met the superiority criterion (lower bound of 95% CI for GMR > 1.0).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
68
The table highlights that all tested Omicron-modified vaccines met the super superiority criterion (GMR lower bound > 1.5).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
69
The table highlights the seroresponse difference and non-inferiority status for participants without prior infection.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
70
The chart compares baseline (Prevax 1MPD) vs post-vaccination GMTs for various BNT162b2 and Bivalent formulations.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
74
The slide uses a circular phylogenetic tree to illustrate the dominance of the Omicron clade (GRA) in recent outbreak sequences.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
75
The chart uses a highlighted box to focus on the Omicron period starting December 2021.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
76
Includes a 3D structural model of the RBD with color-coded mutation sites and a corresponding table of amino acid changes.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
77
Data shows neutralization titers for OMI and Bivalent vaccines against BA.1 and BA.4/5 variants.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
78
The chart uses a log scale for the y-axis (pVN50 titer).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
79
The chart shows that the Omi BA.4/5 and b2 + Omi BA.4/5 vaccines maintain higher neutralization ratios against Omicron sub-lineages compared to the original BNT162b2 vaccine.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
87
Shows log-scale reduction in CFU/ml for pathogens vs no significant impact on beneficial bacteria.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
104
Includes a pie chart of responder status and a line chart showing T-cell expansion over time, plus a summary table of median T-cell percentages.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
105
Shows stacked bar chart of neoantigen immunogenicity and a line chart of IFNy spots over time for responders.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
106
Kaplan-Meier plot showing significant difference in RFS between responders and non-responders.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
109
Includes a citation to a Nature article and specific trial results (Lipo-MERIT).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
110
The chart is a 'spider plot' or 'spaghetti plot' tracking individual patient lesion kinetics.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
111
The chart displays individual patient responses, categorized by treatment type and dose, with markers for partial response (PR) and stable disease (SD/irSD).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit